2019
DOI: 10.5530/ijper.53.2s.57
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and Characterization of Novel N-Benzylbenzimidazole Linked Pyrimidine Derivatives as Anticancer Agents

Abstract: Background: Emergence of resistance to accessible anticancer drugs became a threat to human lives in the recent time. To address this issue, discovery of novel anticancer agents becomes very essential. Benzimidazoles and pyrimidines have been reported to possess potent anticancer activity. Materials and Methods: A hybrid approach has been used, in which core structure of potentially active N-benzyl benzimidazole and pyrimidine derivatives are brought together in to a single molecule. The desired compounds were… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(1 citation statement)
references
References 12 publications
0
1
0
Order By: Relevance
“…[98] The SAR illustrated that the linker between benzimidazole and pyrimidine moieties influenced the activity remarkably and thioether linker was more favorable than the amino linker. [98][99][100][101] Among them, hybrids 44 (Figure 8; IC 50 : 6.5-10.4 µM, MTT assay) and 45 (IC 50 : 2.2-7.3 µM, MTT assay) were found to be most active in each series and hybrid 45 was comparable to nocodazole (IC 50 : 2.0-3.5 µM), whereas hybrid 46 (inhibitory rate: 32.7%-88.4% at 10.0 µM, SRB assay) possessed broad-spectrum activity against a panel of 25 cancer cell lines. Mechanistically, hybrid 45 impaired migration, inhibited the colony formation, arrested the G2/M phase, enhanced microtubule disruption, inhibited tubulin polymerization, and induced apoptosis with triggering of ROS generation and loss of mitochondrial membrane potential.…”
Section: Benzimidazole-cinnamic Acid Hybridsmentioning
confidence: 99%
“…[98] The SAR illustrated that the linker between benzimidazole and pyrimidine moieties influenced the activity remarkably and thioether linker was more favorable than the amino linker. [98][99][100][101] Among them, hybrids 44 (Figure 8; IC 50 : 6.5-10.4 µM, MTT assay) and 45 (IC 50 : 2.2-7.3 µM, MTT assay) were found to be most active in each series and hybrid 45 was comparable to nocodazole (IC 50 : 2.0-3.5 µM), whereas hybrid 46 (inhibitory rate: 32.7%-88.4% at 10.0 µM, SRB assay) possessed broad-spectrum activity against a panel of 25 cancer cell lines. Mechanistically, hybrid 45 impaired migration, inhibited the colony formation, arrested the G2/M phase, enhanced microtubule disruption, inhibited tubulin polymerization, and induced apoptosis with triggering of ROS generation and loss of mitochondrial membrane potential.…”
Section: Benzimidazole-cinnamic Acid Hybridsmentioning
confidence: 99%